<p>MINNEAPOLIS, Nov. 22, 2023 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announc
<p>Organizations are acutely aware of the value of data in today's data-driven financial services world. However, many organizations continue to face a significant challenge: data silos. Th
Leave a Comment